RadNet, Inc. Accounts Receivable
RadNet, Inc. (RDNT) had Accounts Receivable of $241.84 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2026-08-10
- 2026-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $241.84M.
- 2026-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $209.09M.
- 2025-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $200.32M.
- 2025-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $210.55M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current | Accounts Receivable, after Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2026-06-30 | $241.84M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $209.09M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $200.32M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $210.55M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $199.99M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $200.13M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $185.82M 10-K · filed 2026-03-02 | |
| 2024-09-30 | $199.08M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $195.29M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $189.57M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $163.71M 10-K · filed 2025-03-03 | |
| 2023-09-30 | $167.74M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $174.48M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $176.35M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $166.36M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $172.51M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $166.39M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $159.72M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $135.06M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $152.41M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $157.33M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $146.66M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $129.59M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $137.41M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $125.75M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $144.26M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $154.76M 10-K · filed 2021-03-16 | |
| 2019-09-30 | $150.75M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $159.32M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $156.77M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $148.92M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $156.40M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $152.17M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $161.65M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $155.52M 10-K · filed 2019-03-18 | |
| 2017-09-30 | $168.59M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $170.16M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $169.54M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $164.21M 10-K · filed 2018-03-19 | |
| 2016-09-30 | $183.23M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $165.09M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $177.83M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $5.67M 10-K/A · filed 2017-03-31 | $162.84M 10-K · filed 2016-03-15 |
| 2015-09-30 | $159.21M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $155.96M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $153.26M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $7.44M 10-K/A · filed 2016-03-30 | $148.24M 10-K · filed 2015-03-16 |
| 2014-09-30 | $155.01M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $147.02M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $140.63M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $8.60M 10-K/A · filed 2016-03-30 | $133.60M 10-K · filed 2014-03-17 |
| 2013-09-30 | $134.26M 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $139.37M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $134.94M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $8.60M 10-K/A · filed 2014-03-31 | $129.19M 10-K · filed 2013-03-18 |
| 2012-09-30 | $128.64M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $131.44M 10-Q/A · filed 2012-08-30 | |
| 2012-03-31 | $133.97M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $8.33M 10-K/A · filed 2013-11-13 | $128.43M 10-K · filed 2012-03-13 |
| 2011-09-30 | $122.04M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $116.90M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $96.09M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |